Source: Eur Respir J 2001; 17: 163-167
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Costabel U., King T.E.. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J 2001; 17: 163-167

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines Source: Eur Respir Rev 2014; 23:193-214 Year: 2014 Japanese guideline for the treatment of idiopathic pulmonary fibrosis 2017 Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Idiopathic pulmonary fibrosis trials: recommendations for the jury Source: Eur Respir J 2011; 38: 1002-1004 Year: 2011 IPFdatabase – A new tool for a correct application of idiopathic pulmonary fibrosis guidelines Source: International Congress 2014 – ILDs 2 Year: 2014 Development of a national patient charter for idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF clinical Year: 2016 ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias Source: Eur Respir J 2002; 19: 794-796 Year: 2002 ERS Statement: Idiopathic pulmonary fibrosis Source: International Congress 2015 – ERS Task Forces and Guidelines: procedures, methodology and publication Year: 2015 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Eur Respir J, 50 (5) 1700610; 10.1183/13993003.00610-2017 Year: 2017 European Respiratory Society statement: diagnosis and treatment of pulmonary disease in a1-antitrypsin deficiency Source: Guideline 2017 Year: 2017 IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity Source: Eur Respir J 2016; 48: 283-284 Year: 2016 European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity Source: Eur Respir J 2016; 48: 282-283 Year: 2016 Evidence-based treatment strategies in idiopathic pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 163-168 Year: 2013 Genetics in idiopathic pulmonary fibrosis Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine Year: 2016 Revised diagnostic criteria for idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019 Year: 2020 Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early Spanish experience with the European Named patient program (NPP) Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013